Advertisement
Home »

Baricitinib Maintained Efficacy Over 3 Years for Patients With Alopecia

Apr 01, 2024

REFERENCES & ADDITIONAL READING

Senna M, et al. Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2. Presented at: AAD 2024 Annual Meeting, March 8-12, 2024, San Diego, CA.

ABOUT THE CONTRIBUTORS

Author

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement